• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL Back to Search Results
Model Number 1011493-12
Medical Device Problem Codes Inflation Problem (1310); Difficult or Delayed Activation (2577)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 07/31/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The product was not returned to abbott vascular for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints reported from this lot.Balloon inflation issues that can result in deployment issues can be affected by, but not limited to, anatomical conditions, manufacturing, contamination in the inflation lumen, contrast mix ratio, or damage to the device or stent.The investigation was unable to determine a conclusive cause for the reported difficulties.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event or Problem Description
It was reported that the procedure was performed to treat a target lesion in the heavily calcified renal artery.Pre-dilatation was performed twice and the herculink stent delivery system was advanced to the target site.The delivery system balloon was inflated to deploy the stent; however, the balloon did not fully inflate and the stent was not fully expanded.The stent delivery system was removed, with the stent remaining in place at the target lesion.A dilatation catheter was then advanced into the stent and was inflated to fully expand the herculink stent.There was no adverse patient sequela and no clinically significant delay in the procedure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX HERCULINK ELITE STENT SYSTEM
Common Device Name
STENT, RENAL
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10435130
Report Number2024168-2020-06978
Device Sequence Number16948521
Product Code NIN
UDI-Device Identifier08717648078002
UDI-Public08717648078002
Combination Product (Y/N)N
Initial Reporter StateKY
Initial Reporter CountryUS
PMA/510(K) Number
P110001
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 08/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/31/2022
Device Model Number1011493-12
Device Catalogue Number1011493-12
Device Lot Number9061161
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/31/2020
Initial Report FDA Received Date08/20/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-